Ford JM - Search Results

1

Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site.

Tanaka M, Fushimi H, Fuji T, Ford JM. Tanaka M, et al. Among authors: ford jm. Eur Spine J. 1996;5(3):198-200. doi: 10.1007/BF00395514. Eur Spine J. 1996. PMID: 8831124

2

Pharmacokinetics of pamidronate in patients with bone metastases.

Leyvraz S, Hess U, Flesch G, Bauer J, Hauffe S, Ford JM, Burckhardt P. Leyvraz S, et al. Among authors: ford jm. J Natl Cancer Inst. 1992 May 20;84(10):788-92. doi: 10.1093/jnci/84.10.788. J Natl Cancer Inst. 1992. PMID: 1573666

3

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer.

Coleman RE, Houston S, Purohit OP, Rubens RD, Kandra A, Ford J. Coleman RE, et al. Eur J Cancer. 1998 May;34(6):820-4. doi: 10.1016/s0959-8049(97)10155-1. Eur J Cancer. 1998. PMID: 9797692 Clinical Trial.

4

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.

Dodwell DJ, Howell A, Ford J. Dodwell DJ, et al. Br J Cancer. 1990 Jan;61(1):123-5. doi: 10.1038/bjc.1990.25. Br J Cancer. 1990. PMID: 2297483 Free PMC article.

5

Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.

Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard RC, Ford J. Coleman RE, et al. Br J Cancer. 1992 May;65(5):766-8. doi: 10.1038/bjc.1992.161. Br J Cancer. 1992. PMID: 1586605 Free PMC article.

6

Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.

Body JJ, Dumon JC, Piccart M, Ford J. Body JJ, et al. J Bone Miner Res. 1995 Aug;10(8):1191-6. doi: 10.1002/jbmr.5650100808. J Bone Miner Res. 1995. PMID: 8585422 Clinical Trial.

7

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of Cancer.

Vinholes J, Coleman R, Lacombe D, Rose C, Tubiana-Hulin M, Bastit P, Wildiers J, Michel J, Leonard R, Nortier J, Mignolet F, Ford J. Vinholes J, et al. Br J Cancer. 1999 Apr;80(1-2):221-8. doi: 10.1038/sj.bjc.6690506. Br J Cancer. 1999. PMID: 10390000 Free PMC article.

8

A dose-finding study of zoledronate in hypercalcemic cancer patients.

Body JJ, Lortholary A, Romieu G, Vigneron AM, Ford J. Body JJ, et al. J Bone Miner Res. 1999 Sep;14(9):1557-61. doi: 10.1359/jbmr.1999.14.9.1557. J Bone Miner Res. 1999. PMID: 10469284 Free article. Clinical Trial.

9

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.

Brincker H, Westin J, Abildgaard N, Gimsing P, Turesson I, Hedenus M, Ford J, Kandra A. Brincker H, et al. Br J Haematol. 1998 May;101(2):280-6. doi: 10.1046/j.1365-2141.1998.00695.x. Br J Haematol. 1998. PMID: 9609523 Free article. Clinical Trial.

10

Single-cell spatial mapping reveals alteration of cell type composition and tissue microenvironment during early colorectal cancer formation.

Guha TK, Esplin ED, Horning AM, Chiu R, Paul K, Weimer AK, Becker WR, Laquindanum R, Mills MA, Esplin DG, Shen J, Monte E, White S, Karathanos TV, Cotter D, Bi J, Ladabaum U, Longacre TA, Curtis C, Greenleaf WJ, Ford JM, Snyder MP. Guha TK, et al. Among authors: ford jm. bioRxiv [Preprint]. 2024 Nov 21:2024.11.20.622725. doi: 10.1101/2024.11.20.622725. bioRxiv. 2024. PMID: 39605357 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters